参考文献/References:
[1]Tesfaye S,Boulton AJ,Dyck PJ,et al.Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments[J].Diabetes Care,2010,33(10):2285-2293.[2]Assessment:Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology[J].Neurology,1996,46(3):873-880.[3]Dimitropoulos G,Tahrani AA,Stevens MJ.Cardiac autonomic neuropathy in patients with diabetes mellitus[J].World J Diabetes,2014,5(1):17-39.[4]Huang Y,Chen H,Hu D,et al.Blood hemoglobin A1c might predict adverse differences in heart rate variability in a diabetic population: Evidence from the Midlife in the United States (MIDUS) study[J].Front Endocrinol (Lausanne),2022,13:921287.[5]Zoppini G,Cacciatori V,Raimondo D,et al.Prevalence of cardiovascular autonomic neuropathy in a cohort of patients with newly diagnosed type 2 diabetes: the Verona newly diagnosed type 2 diabetes study (VNDS)[J].Diabetes Care,2015,38(8):1487-1493.[6]Ewing DJ,Clarke BF.Autonomic neuropathy:its diagnosis and prognosis[J].Clin Endocrinol Metab,1986,15(4):855-888.[7]Dhumad MM,Hamdan FB,Khudhair MS,et al.Correlation of staging and risk factors with cardiovascular autonomic neuropathy in patients with type II diabetes mellitus[J].Sci Rep,2021,11(1):3576.[8]Liu YS,Peng Y,Jin J,et al.Insulin resistance is independently associated with cardiovascular autonomic neuropathy in type 2 diabetes[J].J Diabetes Investig,2021,12(9):1651-1662.[9]Chung MY,Park SY,Chung JO,et al.Plasma sphingosine 1-phosphate concentrations and cardiovascular autonomic neuropathy in individuals with type 2 diabetes[J].Sci Rep,2020,10(1):12768.[10]Migisha R,Agaba DC,Katamba G,et al.Prevalence and correlates of cardiovascular autonomic neuropathy among patients with diabetes in Uganda: ahospital-based cross-sectional study[J].Glob Heart,2020,15(1):21.[11]Devi RV,Subramaniam V,Adole PS,et al.Cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus and its association with serum omentin and leptin[J].J Family Med Prim Care,2020,9(6):2926-2930.[12]Pan Q,Guo LX,Wang XX,et al.2245-PUB:the epidemiology and diagnosis of diabetic cardiovascular autonomic neuropathy:a multicenter clinical study[J].Diabetes,2019,68(Supplement_1):2245-PUB.[13]BhuyanAK,Baro A,Sarma D,et al.A study of cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: anortheast India experience[J].Indian J Endocrinol Metab,2019,23(2):246-250.[14]Chung JO,Park SY,Han JH,et al.Serum apolipoprotein A-1 concentrations and the prevalence of cardiovascular autonomic neuropathy in individuals with type 2 diabetes[J].J Diabetes Complications,2018,32(4):357-361.[15]Mot?觍t?觍ianu A,Maier S,Bajko Z,et al.Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients[J].BMC Neurol,2018,18(1):1-9.[16]Chung JO,Park SY,Cho DH,et al.Anemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes[J].Medicine(Baltimore),2017,96(15):e6586.[17]Jun JE,Lee SE,Lee YB,et al.Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients[J].Cardiovasc Diabetol,2017,16(1):127.[18]Akbar M,Bhandari U,Habib A,et al.Potential association of triglyceride glucose index with cardiac autonomic neuropathy in type 2 diabetes mellitus patients[J].J Korean Med Sci,2017,32(7):1131-1138.[19]Jun JE,Jin SM,Baek J,et al.The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes[J].Cardiovasc Diabetol,2015,14:70.[20]Mot?觍t?觍ianu A,B?觍laｓa R,Void?觍zan S,et al.Cardiovascular autonomic neuropathy in context of other complications of type 2 diabetes mellitus[J].Biomed Res Int,2013,2013:507216.[21]Jung CH,Kim BY,Kim CH,et al.Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients[J].Cardiovasc Diabetol,2012,11:24.[22]Voulgari C,Psallas M,Kokkinos A,et al.The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes[J].J Diabetes Complications,2011,25(3):159-167.[23]Pappachan JM,Sebastian J,Bino BC,et al.Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis[J].Postgrad Med J,2008,84(990):205-210.[24]徐梦珠,吴坚,郝娟,等.2型糖尿病患者心脏自主神经病变相关危险因素[J].医学综述,2022,28(2):372-379.[25]刘颖珊.2型糖尿病心血管自主神经病变相关危险因素分析[D].广州:南方医科大学,2020.[26]张桂玲,刘莉,刘静芹,等.2型糖尿病患者血尿酸与心脏自主神经病变相关性的研究[J].中国急救复苏与灾害医学杂志,2016,11(6):643-644.[27]刘丽娟,杜煜,黄伟,等.2型糖尿病患者血尿酸、胰岛素抵抗与心脏自主神经病变的相关性研究[J].中国医师杂志,2016,18(9):1403-1405.[28]王吾勇.2型糖尿病患者血清FFA与DCAN相关性研究[J].中国热带医学,2014,14(9):1090-1092.[29]刘烈,张晓宇,朱少辉,等.2型糖尿病心脏自主神经病变临床特征和危险因素分析[J].岭南心血管病杂志 2013,19(4):463-468.[30]刘静芹,尹贺欣,刘凯,等.糖尿病患者心脏自主神经病变相关因素研究[J].中国慢性病预防与控制,2008,16(4):371-372,381.[31]Yun JS,Park YM,Cha SA,et al.Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes[J].Cardiovasc Diabetol,2018,17(1):109.[32]Dimitropoulos G,Tahrani AA,Stevens MJ.Cardiac autonomic neuropathy in patients with diabetes mellitus[J].World J Diabetes,2014,5(1):17-39.[33]Luevano-Contreras C,Chapman-Novakofski K.Dietary advanced glycation end products and aging[J].Nutrients,2010,2(12):1247-1265.[34]Santos Breder IS,Sposito AC.Cardiovascular autonomic neuropathy in type 2 diabetic patients[J].Rev Assoc Med Bras,2019,65(1):56-60.[35]Ziegler D,Buchholz S,Sohr C,et al.Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients[J].Acta Diabetol,2015,52(1):65-72.[36]Spallone V.Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet[J].Diabetes Metab J,2019,43(1):3-30.[37]Baldasseroni S,Urso R,Maggioni AP,et al.Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry[J].Nutr Metab Cardiovasc Dis,2012,22(5):442-448.[38]Erden M,Kocaman SA,Poyraz F,et al.Incremental effects of serum uric acid levels, autonomic dysfunction, and low-grade inflammation on nocturnal blood pressure in untreated hypertensive patients and normotensive individuals[J].Turk Kardiyol Dern Ars,2011,39(7):531-539.[39]Liao XP,Zhu HW,Zeng F,et al.The association and interaction analysis of hypertension and uric acid on cardiovascular autonomic neuropathy[J].J Endocrinol Invest,2015,38(10):1075-1082.[40]Watkins PJ.Cardiac denervation in diabetic neuropathy[J].Ann Intern Med,1980,92(2_Part_2):304.[41]Vinik AI,Ziegler D.Diabetic cardiovascular autonomic neuropathy[J].Circulation,2007,115(3):387-397.[42]Spallone V,Ziegler D,Freeman R,et al.Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management[J].Diabetes Metab Res Rev,2011,27(7):639-653.[43]Schroeder EB,Liao DP,Chambless LE,et al.Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study[J].Hypertension,2003,42(6):1106-1111.[44]Ayad F,Belhadj M,Pariés J,et al.Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications[J].Diabet Med,2010,27(7):804-811.[45]Guarino D,Nannipieri M,Iervasi G,et al.The role of the autonomic nervous system in the pathophysiology of obesity[J].Front Physiol,2017,8:665.[46]Andersen ST,Witte DR,Fleischer J,et al.Risk factors for the presence and progression of cardiovascular autonomic neuropathy in type 2 diabetes: addition-Denmark[J].Diabetes Care,2018,41(12):2586-2594.[47]Wang CCL,Hess CN,Hiatt WR,et al.Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations[J].Circulation,2016,133(24):2459-2502.[48]Paulus WJ,Dal Canto E.Distinct myocardial targets for diabetes therapy in heart failure with preserved or reduced ejection fraction[J].JACC Heart Fail,2018,6(1):1-7.[49]Tahrani AA,Dubb K,Raymond NT,et al.Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study[J].Diabetologia,2014,57(6):1249-1256.[50]Laursen JC,Rasmussen IKB,Zobel EH,et al.The association between cardiovascular autonomic function and changes in kidney and myocardial function in type 2 diabetes and healthy controls[J].Front Endocrinol (Lausanne) ,2021,12:780679.[51]Huang CC,Lee JJ,Lin TK,et al.Diabetic retinopathy is strongly predictive of cardiovascular autonomic neuropathy in type 2 diabetes[J].J Diabetes Res,2016,2016:6090749.[52]Chen HT,Lin HD,Won JG,et al.Cardiovascular autonomic neuropathy, autonomic symptoms and diabetic complications in 674 type 2 diabetes[J].Diabetes Res Clin Pract,2008,82(2):282-290.[53]Low PA,Benrud-Larson LM,Sletten DM,et al.Autonomic symptoms and diabetic neuropathy: a population-based study[J].Diabetes Care,2004,27(12):2942-2947.[54]Whitsel EA,Boyko EJ,Siscovick DS.Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes:a meta-analysis[J].Diabetes Care,2000,23(2):241-247.[55]Hansen CS,Jensen JS,Ridderstr?覽le M,et al.Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes[J].J Diabetes Complications,2017,31(1):202-208.[56]Jung CH,Jung SH,Kim KJ,et al.The relationship between vitamin D status and cardiac autonomic neuropathy in patients with type 2 diabetes mellitus[J].Diab Vasc Dis Res,2015,12(5):342-351.[57]Maser RE,Lenhard MJ,Pohlig RT.Vitamin D insufficiency is associated with reduced parasympathetic nerve fiber function in type 2 diabetes[J].EndocrPract,2015,21(2):174-181.[58]Lopresti AL.Association between Micronutrients and Heart Rate Variability: A Review of Human Studies[J].Adv Nutr,2020,11(3):559-575. [59]Neves JAJ,De Matos MR,Ramalho T,et al.Increased leukotriene B4 plasma concentration in type 2 diabetes individuals with cardiovascular autonomic neuropathy[J].Diabetol Metab Syndr,2020,12(1):99.[60]Herder C,Schamarek I,Nowotny B,et al.Inflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes[J].Heart,2017,103(1):63-70.[61]Bhati P,Alam R,Moiz JA,et al.Subclinical inflammation and endothelial dysfunction are linked to cardiac autonomic neuropathy in type 2 diabetes[J].J Diabetes Metab Disord,2019,18(2):419-428.[62]Moradi N,Fadaei R,Emamgholipour S,et al.Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease[J].PLoS One,2018,13(1):e0192159.[63]Yang JP,Zhao DN,Chen Y,et al.Association of serum CTRP9 levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus[J].J Diabetes Investig,2021,12(8):1442-1451.[64]Ciccacci C,Latini A,Greco C,et al.Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes[J].J Diabetes Complications,2018,32(1):11-17.[65]Ciccacci C,Morganti R,Di Fusco D,et al.Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes[J].Acta Diabetol,2014,51(4):663-671.[66]Luo DH,Wan X,Liu JM,et al.Optimally estimating the sample mean from the sample size, Median, mid-range, and/or mid-quartile range[J].Stat Methods Med Res,2018,27(6):1785-1805.[67]Wan X,Wang WQ,Liu JM,et al.Estimating the sample mean and standard deviation from the sample size, Median, range and/or interquartile range[J].BMC Med Res Methodol,2014,14:135.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(11):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(11):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(11):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(11):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(11):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(11):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[7]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(11):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[8]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Journal of Medical Information,2022,35(11):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[9]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Journal of Medical Information,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[10]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(11):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]